Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
201.60
-2.11 (-1.04%)
At close: Oct 31, 2025, 4:00 PM EDT
205.64
+4.04 (2.00%)
After-hours: Oct 31, 2025, 6:06 PM EDT
Ascendis Pharma Analyst Ratings
Total Analysts
17
Consensus Rating
Strong Buy
Price Target
$245.76
Upside
+21.90%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Strong Buy Initiates $271 | Strong Buy | Initiates | $271 | +34.42% | Oct 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $203 → $254 | Buy | Maintains | $203 → $254 | +25.99% | Oct 13, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $260 → $264 | Buy | Maintains | $260 → $264 | +30.95% | Oct 9, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $227 → $230 | Strong Buy | Maintains | $227 → $230 | +14.09% | Sep 2, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $254 → $260 | Buy | Maintains | $254 → $260 | +28.97% | Aug 19, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $243 → $290 | Strong Buy | Maintains | $243 → $290 | +43.85% | Aug 8, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $210 → $230 | Buy | Maintains | $210 → $230 | +14.09% | Aug 8, 2025 |
| Wedbush | Wedbush | Buy Maintains $212 → $220 | Buy | Maintains | $212 → $220 | +9.13% | Aug 8, 2025 |
| UBS | UBS | Strong Buy Maintains $306 → $307 | Strong Buy | Maintains | $306 → $307 | +52.28% | Aug 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $200 → $203 | Buy | Maintains | $200 → $203 | +0.69% | Aug 8, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $289 → $295 | Buy | Maintains | $289 → $295 | +46.33% | Aug 8, 2025 |
| Stifel | Stifel | Strong Buy Maintains $212 → $254 | Strong Buy | Maintains | $212 → $254 | +25.99% | Aug 8, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $245 → $254 | Buy | Maintains | $245 → $254 | +25.99% | Jul 29, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $213 → $243 | Strong Buy | Maintains | $213 → $243 | +20.54% | Jul 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $250 | Buy | Initiates | $250 | +24.01% | Jul 3, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $215 → $224 | Buy | Maintains | $215 → $224 | +11.11% | Jun 13, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.